18F-FAPI-RGD PET/CT in Various Tumor Types
NCT06094530 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-10-23
Summary
The clinical feasibility of 18F-FAPI-RGD PET/CT will be evaluated in 100 patients with various types of tumor, and the results will be compared with those of 18F-FDG.
Conditions
- Neoplasms
Sponsors & Collaborators
-
Sichuan Provincial People's Hospital
lead OTHER
Principal Investigators
-
Hao Wang, Doctor · Sichuan Provincial People's Hospital
Eligibility
- Min Age
- 10 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-04-10
- Primary Completion
- 2024-09-30
- Completion
- 2024-10-31
Countries
- China
Study Locations
More Related Trials
-
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
NCT06126705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
NCT05749302 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection
NCT06945432 ·Status: COMPLETED
-
To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
NCT06205888 ·Status: NOT_YET_RECRUITING
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
18F-FAPI and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05485792 ·Status: UNKNOWN ·Phase: NA
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD
NCT06638034 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112 ·Status: RECRUITING
-
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
NCT06206642 ·Status: COMPLETED ·Phase: NA
-
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
NCT06182644 ·Status: RECRUITING ·Phase: NA
-
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application
NCT06270394 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of 18F-FAPI-RGD in Interstitial Lung Disease Associated With Connective Tissue Disease
NCT06143540 ·Status: RECRUITING
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer
NCT04941872 ·Status: COMPLETED ·Phase: NA
-
Tracer Targeting FAP PET Imaging in Patients
NCT05691894 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT
NCT05430841 ·Status: COMPLETED ·Phase: NA
-
FAPI PET/CT in Various FAP-Related Disease Patients
NCT06688071 ·Status: RECRUITING
-
[18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity
NCT05806333 ·Status: UNKNOWN ·Phase: NA
-
Study of 18F-FAPI Applied to Gastrointestinal Cancer
NCT05788874 ·Status: UNKNOWN
-
68Ga-FAPI PET/CT in Malignant Tumors
NCT05034146 ·Status: RECRUITING ·Phase: NA
-
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
NCT05543954 ·Status: RECRUITING ·Phase: EARLY_PHASE1